{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:43:18Z","timestamp":1790170998925,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.urolonc.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T17:58:05Z","timestamp":1462039085000},"page":"338.e19-338.e27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic value of UTX expression in patients with clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Jiajun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilai","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2016.03.012_bib1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2016.03.012_bib2","first-page":"137","article-title":"International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012","volume":"50","author":"Hes","year":"2014","journal-title":"Cesk Patol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMra043172","article-title":"Renal-cell carcinoma","volume":"353","author":"Cohe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2016.03.012_bib4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Fuhrman","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","article-title":"An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score","volume":"168","author":"Frank","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00345-010-0540-8","article-title":"Prognostic factors in renal cell carcinoma","volume":"28","author":"Volpe","year":"2010","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1470-2045(12)70292-9","article-title":"Biomarkers in personalised treatment of renal-cell carcinoma","volume":"13","author":"Shariat","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2015.02.008","article-title":"The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer","volume":"208","author":"Liao","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.urolonc.2016.03.012_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ng0210-100","article-title":"Deregulation of H3K27 methylation in cancer","volume":"42","author":"Martinez-Garcia","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2016.03.012_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ceb.2015.10.003","article-title":"PRC2 mediated H3K27 methylations in cellular identity and cancer","volume":"37","author":"Conway","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4143\/crt.2014.46.3.209","article-title":"Regulation and role of EZH2 in cancer","volume":"46","author":"Yamaguchi","year":"2014","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.urolonc.2016.03.012_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.urolonc.2016.03.012_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ng.349","article-title":"Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer","volume":"41","author":"Van Haaften","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2016.03.012_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2016.03.012_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2016.03.012_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2014-05-577270","article-title":"The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia","volume":"125","author":"Van der Meulen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.urolonc.2016.03.012_bib18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.15252\/embr.201540244","article-title":"UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1","volume":"16","author":"Choi","year":"2015","journal-title":"EMBO Rep"},{"key":"10.1016\/j.urolonc.2016.03.012_bib19","first-page":"926","article-title":"Clinical significance of high expression with UTX in renal cell carcinoma","volume":"46","author":"Wang","year":"2014","journal-title":"Beijing Da Xue Xue Bao"},{"key":"10.1016\/j.urolonc.2016.03.012_bib20","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1158\/0008-5472.CAN-11-2260","article-title":"Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src\/PI3K\/Akt pathway","volume":"71","author":"Liu","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2016.03.012_bib21","first-page":"5419","article-title":"Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody","volume":"46","author":"Budwit-Novotny","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2016.03.012_bib22","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2016.03.012_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/1078-0432.CCR-05-1533","article-title":"Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer","volume":"12","author":"Collett","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2016.03.012_bib24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.urolonc.2010.09.005","article-title":"Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder","volume":"30","author":"Wang","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1349-7006.2006.00203.x","article-title":"Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer","volume":"97","author":"Matsukawa","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urolonc.2016.03.012_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1476-4598-9-265","article-title":"Clinical significance of Polycomb gene expression in brain tumors","volume":"9","author":"Crea","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.urolonc.2016.03.012_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/pin.12001","article-title":"Expression of EZH2 in renal cell carcinoma as a novel prognostic marker","volume":"62","author":"Lee","year":"2012","journal-title":"Pathol Int"},{"key":"10.1016\/j.urolonc.2016.03.012_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bju.12702","article-title":"Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma","volume":"117","author":"Liu","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2016.03.012_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbrc.2010.07.061","article-title":"The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase","volume":"399","author":"Terashima","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.urolonc.2016.03.012_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1101\/gad.1882610","article-title":"The histone demethylase UTX enables RB-dependent cell fate control","volume":"24","author":"Wang","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.urolonc.2016.03.012_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature11272","article-title":"The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming","volume":"488","author":"Mansour","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2016.03.012_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12038-009-0034-2","article-title":"Retinoblastoma protein: a central processing unit","volume":"34","author":"Poznic","year":"2009","journal-title":"J Biosci"},{"key":"10.1016\/j.urolonc.2016.03.012_bib33","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/MCB.01633-09","article-title":"The H3K27me3 demethylase dUTX is a suppressor of Notch- and Rb-dependent tumors in Drosophila","volume":"30","author":"Herz","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib34","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/MCB.01506-06","article-title":"Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth","volume":"27","author":"Issaeva","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.urolonc.2016.03.012_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.1149042","article-title":"Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination","volume":"318","author":"Le","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2016.03.012_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4161\/epi.28298","article-title":"The H3K27me3 demethylase UTX in normal development and disease","volume":"9","author":"Van der Meulen","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.urolonc.2016.03.012_bib37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/cr.2012.136","article-title":"A new horizon for epigenetic medicine?","volume":"23","author":"Chen","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.urolonc.2016.03.012_bib38","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature11262","article-title":"A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response","volume":"488","author":"Kruidenier","year":"2012","journal-title":"Nature"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916000946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143916000946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:07:20Z","timestamp":1761041240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143916000946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1078143916000946"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.03.012","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of UTX expression in patients with clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}